Nexii provides a building solution that enables the rapid construction of sustainable and resilient buildings. Nexii is a green construction technology company committed to transforming the world’s buildings to be healthy, more affordable, and truly sustainable.
Swift Health Systems is a stealth stage medical device company developing INBRACE: a revolutionary, easy to use, wide indication, personalized orthodontic system hidden behind the teeth. Our patented self-guiding technology uses light and continuous forces to gently correct your smile with less pain and fewer doctor visits. INBRACE is FDA registered and a catalyst for disruption in orthodontics. INBRACE increases the number of people who will seek orthodontic treatment by addressing the top concerns for patients while driving practice growth for clinicians. Our platform leverages digital treatment planning, computer modeling, and direct digital manufacturing to create a scalable, patient customized solution that delivers the standard of care across the entire range of orthodontic cases.
Divergent has created the world's first end-to-end software-hardware production system for industrial digital manufacturing – the Divergent Adaptive Production System (DAPS™) – allowing customers to design, additively manufacture, and automatically assemble complex structures for automotive, aerospace, and defense applications. DAPS transforms the economics and environmental impact of manufacturing complex structures for vehicles of all types by optimizing designs, dematerializing structures, and eliminating upfront capex.
Soli Organic is an indoor farming startup that sells fresh organic culinary herbs. The company provides a 365-day supply of fresh, organic herbs to grocery stores, so millions of consumers can now eat locally all year. Their products are healthy, delicious, and aimed at making the world a lot more flavorful.
Secure Transfusion Services is a life sciences company that aims to improve the quality and availability of transfusable blood components. The company is dedicated to helping the blood industry modernize and stabilize by enhancing the vital role that nonprofit blood banks play in ensuring the nation's blood supply.
Aerobiotix is a privately held company specializing in the development and manufacture of proprietary environmental management devices for use in institutional healthcare, home health, and commercial settings.
Interior Define (ID) is a pioneering digitally-native and vertically-integrated furniture brand, offering the most compelling and in-depth custom furniture experience in the middle of the market. ID makes customization easy: sofas may be tailored by size, fabric, configuration, leg style, and sit, providing an experience akin to high-end custom brands. Since every sofa (and now beds and dining) is made to order, inventory overhead is all but eliminated, allowing the brand to sell at accessible, middle market prices. This creates a unique customer experience further highlighted by complimentary white glove delivery, a standard 365-day return policy, and high-touch shopping process. Online, customers can view all pieces and custom options in 360 degrees, and order free fabric swatches to explore the product in home. Customers can also use ID's augmented reality (AR) app to view furniture and fabrics in their homes. Though a digitally-native brand, at ID's Guideshop locations, guests can experience firsthand the unique sit and style of each sofa and receive one-on-one consultations with expert team members. ID Guideshop locations can be visited in New York (Soho), Chicago (Lincoln Park), San Francisco (Hayes Valley), Los Angeles (Fairfax, La Brea), Boston (Back Bay), and Austin (Domaine Northside).
IMV Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies and vaccines for infectious diseases, including COVID-19. Utilizing its proprietary delivery platform, the company targets immune cells within the human body to enhance their ability to attack cancer cells. Its lead candidate, DPX-Survivac, is a targeted T cell therapy that has shown promise in multiple Phase 1 and 1b trials for late-stage ovarian cancer and relapsed/refractory DLBCL. DPX-Survivac is currently undergoing Phase 2 clinical trials across six cancer types and is being evaluated in combination with Keytruda. IMV is also progressing with a DPX-based vaccine for COVID-19, developed in collaboration with experts in infectious diseases, and is working on a vaccine targeting the respiratory syncytial virus strain A. Founded in 2000 and based in Dartmouth, Canada, the company was previously known as Immunovaccine Inc. before rebranding in 2018.
Everstream Analytics is a supply chain risk analytics company that delivers actionable insights to increase the resilience and agility of clients' supply chains, protecting revenue and reputation. It integrates with the clients' procurement, logistics, and business continuity platforms to deliver global, end-to-end visibility of supply chain risk. The company combines data science, proprietary intelligence, and multilingual specialists to monitor global risk and events in real-time to enable clients to act sooner. embeds risk analytics into decision making during planning and execution across all functions and phases of clients' supply chains.
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. The company was founded in 2007 and is based in Newton, Massachusetts, United States.
Nogin is an intelligent commerce platform that enables leading brands to keep pace with big retail, drive predictable profitability, and exponential growth, and grow rapidly into the future of commerce. Brands selling direct to consumers (D2C) and through online channel partners can use the Nogin Intelligent Commerce technology, a cloud-based e-commerce environment. Customers of Nogin are free to manage as much or as little of the infrastructure as they see fit while concentrating on their brands.
Embody Inc is a regenerative medicine company that focuses on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration. The company specializes in biomaterial design, bio-fabrication, nanotechnology, and medical devices. It was founded in 2015 and is headquartered in Norfolk, Virginia.
Embody Inc is a regenerative medicine company that focuses on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration. The company specializes in biomaterial design, bio-fabrication, nanotechnology, and medical devices. It was founded in 2015 and is headquartered in Norfolk, Virginia.
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic disorders. The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases. The company's rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for congenital disorders of glycosylation and CERC-006, an oral mTORc1/c2 inhibitor in development for the treatment of complex lymphatic malformations. The company is also developing two monoclonal antibodies, CERC-002, and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for treatment of severe pediatric-onset Crohn's disease and COVID-19 acute respiratory distress syndrome. CERC-007 targets the cytokine IL-18 and is in clinical development for the treatment of Still’s disease (adult onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA)) and multiple myeloma (MM). CERC-006, 801, 802 and 803 have all received Orphan Drug Designation and Rare Pediatric Disease Designation, which makes all four eligible for a priority review voucher upon FDA approval.
RepTrak is the creator of an enterprise software platform and subscription-based service that helps businesses understand, improve, and protect their corporate reputation through key data analytics. Its proprietary RepTrak model is the global standard for measuring and analyzing global sentiment across industries and geographies, using proven data science models and machine learning techniques. The RepTrak Company, founded in 2004, owns a large reputation benchmarking database of over 1 million company ratings per year, which is used by CEOs, boards, and executives in over 60 countries worldwide.
LiquiGlide is a viable technology that allows viscous liquids to slide effortlessly. LiquiGlide is the first company to create permanently wet slippery surfaces. There is no other durable solution that makes viscous liquids slide easily.
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic disorders. The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases. The company's rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for congenital disorders of glycosylation and CERC-006, an oral mTORc1/c2 inhibitor in development for the treatment of complex lymphatic malformations. The company is also developing two monoclonal antibodies, CERC-002, and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for treatment of severe pediatric-onset Crohn's disease and COVID-19 acute respiratory distress syndrome. CERC-007 targets the cytokine IL-18 and is in clinical development for the treatment of Still’s disease (adult onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA)) and multiple myeloma (MM). CERC-006, 801, 802 and 803 have all received Orphan Drug Designation and Rare Pediatric Disease Designation, which makes all four eligible for a priority review voucher upon FDA approval.
Launched in 2016, Fingerlix is the brainchild of 4 foodies. Their purpose is to spread Joy through food by easing up cooking and exploration. They believe that Joy stems from spending more time with family and less time in the kitchen. Joy is maximum when they discover something new and different that entices their taste buds. Joy also comes from making healthier, happier food choices that leave us with a feeling of goodness. Through their Ready-to-Cook & Ready-to-Eat food options, they want to be a part of your cooking journey, partnering you, everyday - day after day. And they do their best to make that happen – sourcing choicest ingredients, maintaining extremely high hygiene standards and above all, inspiring your magical touch to transform every dish into ‘Your dish’.
Alula Holdings is a smart security company offering a completely integrated smart security platform. The platform delivers security simplified for independent security dealers and installers and the customers who rely on their service and expertise. The company dedicated to making smart security simple for dealers. It was founded in 2018 and is based in Hudson, Wisconsin.
We passionately believe that infectious disease patients should be treated with the same precision that cancer patients receive today. As our population increases, our economies become more global, and we continue over-usage of broad-spectrum antibiotics, infectious diseases are going to continue to spread and become more pernicious. Our clinical practices must evolve with disease to become more precise in our diagnostic and treatment tools. At IDbyDNA, our goal is to accelerate these solutions and uncover the microbial world to reduce infectious disease-associated morbidity and mortality
Corinth MedTech, a small startup company located in Cupertino, CA, and founded in 2014, developed a bipolar transurethral and transcervical resection system intended for endoscopically controlled tissue removal for male patients diagnosed with benign prostatic hyperplasia (BPH), and female patients diagnosed with Abnormal Uterine Bleeding (AUB), fibroids and/or polyps requiring Hysteroscopic tissue removal.
Sonex Health reduces invasiveness, improves safety, and lowers the cost of care through transformative ultrasound. “Refined simplicity” is the guiding principle behind Sonex Health. To drive efforts and innovations that result in elegant, effective solutions to some of the healthcare system’s most pressing needs. Mayo Clinic physicians Darryl Barnes, MD and Jay Smith, MD, and business operations expert Aaron Keenan founded Sonex Health in 2014. Sonex Health has developed the SX-One MicroKnife(R) with Meerkat Technology™ to treat carpal tunnel syndrome in a novel fashion, termed Micro-invasive Carpal Tunnel Release. This innovation allows a procedure that once took place in an operating room to be safely and effectively performed in a surgery center or office setting, resulting in rapid patient recovery, improved cosmesis, and reduced costs. The ultra-low-profile SX-One MicroKnife with Meerkat Technology is an innovative surgical device that enables physicians to perform Micro-invasive Carpal Tunnel Release surgery through a single micro-incision under ultrasound guidance, or with a traditional mini-open incision without ultrasound guidance. The SX-One MicroKnife utilizes a micro-incision that’s up to five times smaller than the incision made during traditional CTR surgery—an incision so small, it can be closed with a small adhesive bandage or strip instead of sutures or stitches. The result is a low-trauma surgical environment that has been associated with a more rapid recovery. Immobilization is unnecessary so patients can begin rehabilitation and get back to their jobs and lives.
Getaround empowers users to instantly rent and drive great cars shared by people in their city. Cars can be rented by the hour, or the day, with a $1M insurance policy and 24/7 roadside assistance included. By using its app, people skip the lines and paperwork at traditional rental car counters, and the hassle of buying and maintaining a car. Powered by Getaround ConnectTM, the patented connected car technology, Getaround creates a fun and safe carsharing experience is without the need to meet the car owner, carry an access card, or coordinate picking up a car key. People share everything from a Prius to a Tesla and earn thousands in extra income each year, offsetting the high cost of car ownership while also making a positive impact on the environment.
The Topia global talent mobility platform enables businesses to deliver mobility as part of a broader talent and business strategy with enhanced employee experiences. This drives competitive advantage by ensuring the right people are in the right place at the right time. The Topia platform automates the entire global talent mobility process, from scenario-based planning, compliance risk management, expat payroll, reporting, and more. Topia powers global talent mobility programs for many of the world's most trusted brands, including Schneider Electric, Dell, Veolia, Equinor, AXA.
Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests. It has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. It was incorporated in 2011 and is based in Seattle, Washington.
Ceribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective. The company creates and validates an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter, which allows for faster results and clinical decision-making. The Ceribell EEG System can be set up by any healthcare provider in 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that can only be diagnosed with EEG, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications.
Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need. It was founded in 2015 and headquartered in Pennsylvania, United States.
OutboundEngine is an Austin, TX-based marketing technology company that helps businesses grow by making online marketing simple. The company’s SaaS platform automates email marketing, social media posting, online review collection and more for over 10,000 customers. Founded in 2012, OutboundEngine is ranked No. 95 on the Inc. 5000 and has been consistently named a top workplace in Austin. For more information, please visit www.outboundengine.com
The Aveta™ System is an all-in-one tissue removal solution for intrauterine pathology. Because of its small footprint, it can be equally integrated into any exam, procedure, or operating room—offering patients and physicians more advanced, convenient, and cost-effective procedure options. Wide-angle HD hysteroscopy with electronic upright image-lock, advanced fluid management with improved pressure and fluid deficit control, and the smallest insertion diameter with the largest working channel allows optimized tissue resection.
Encore Dermatology is a privately held fully-integrated dermatology company that provides prescription therapies and medical devices to dermatologists. It provides a range of medical dermatology products, treating a number of topical disease states that enable patients to get improved skin care and treatment with ease. Encore Dermatology was established in 2015 and is headquartered in Malvern, Pennsylvania.
Mustang Bio is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The products under development are - CD123, CD20, and CS1.
CSA Medical provides cryotherapy systems. It offers CryoSpray Ablation system, which enables the physicians to freeze, destroy, and remove unwanted tissues, as well as transports liquid nitrogen that is passed through a standard endoscope. CSA Medical was formerly known as Crymed Technologies and changed its name to CSA Medical in April 2006. The company was incorporated in 1993 and is based in Lutherville Timonium, Maryland.
MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.
New Signature delivers an amazing customer experience to customers across all company sizes, geographies and industries and helps them solve business challenges using Microsoft solutions. Our process driven approach is specifically designed to consistently deliver success to customers that need support for complex projects that require substantial creativity, strategic vision and stellar technology expertise. We help our customers make major investment decisions through rigorous economic analysis that presents the value of Microsoft solutions. We then provide hands-on IT expertise to plan, design, deploy, customize and extend, manage and support their Microsoft solutions. New Signature ensures a maximum ROI by delivering customized user adoption and learning solutions for business users and IT professionals.
Ontrak provides specialized health management services to health plans, employers and unions through a network of licensed and company managed health care providers. Catasys’ integrated substance dependence program, OnTrak is designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching and online tools to aid members in their recovery.
Since 2003, we help companies driving digital innovation, with disruptive methodologies. We design new brands, new services and new products, in collaboration with our clients and their partners. We assist large groups, start-ups and SMEs in the conduct of disruption (Disrupt), of digital experience design (Design), and the conduct of growth (Scale). Our approach is different from a digital agency: we are structured as a consultancy, with concrete execution abilities in design and in marketing.
Audacy is a space communications service provider enabling continuous satellite and launch vehicle connectivity from the launchpad to the Moon. Its mission is to deliver anytime, highly operable connectivity that advances humankind to an unparalleled age of space exploration and discovery. The company was founded in 2015 and headquartered in Mountain View, California.
Conventus Orthopaedics provides a range of orthopedic and sports medicine services. The physicians specialize in orthopedic surgery, reconstructive surgery, spine surgery, joint replacement, sports medicine, physical therapy, and operative care of fractures, arthritis, strains, sprains, and sports-related injuries. Conventus was formed by a team of medical professionals with the sole purpose of creating less invasive ways to treat challenging periarticular fractures. By leveraging advanced nitinol technology, the Conventus team has developed a platform technology that provides robust fixation and creates reliable repairs. The company was incorporated in 2009 and is based in Maple Grove, Minnesota.
IntelePeer is a communications automation platform that leverages generative AI to streamline customer interactions. It helps businesses reduce operational costs while improving customer experiences through efficient automation solutions. The platform integrates seamlessly with existing systems to optimize communication processes across various channels.
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion. The company's products, VivAer for nasal airway obstruction and RhinAer for chronic rhinitis, leverage its proprietary temperature-controlled technology, which allows ENT physicians to improve patients’ symptoms with technologies that are appealing alternatives to invasive surgery.
Titan Pharmaceuticals, Inc. is a biopharmaceutical Company developing proprietary therapeutics primarily for the treatment of serious medical disorders. Titan’s principal asset is Probuphine®, the first slow-release implant formulation of buprenorphine hydrochloride (“buprenorphine”), designed to maintain a stable, round-the-clock blood level of the medicine in patients for up to six months following a single treatment. The outpatient treatment of opioid dependence with daily dosed sublingual buprenorphine formulations represents a $1.3 billion market in the U.S., and a seven day transdermal patch formulation of buprenorphine for the treatment of chronic pain was launched in the U.S. in 2011. This novel implant formulation is inserted subdermally in a patient’s upper arm providing continuous medication, and has the potential to enhance patient compliance to treatment, and limit diversion for illicit use and accidental exposure to the sublingual formulations. The New Drug Application (NDA) was submitted to the FDA in October, 2012 seeking approval for treatment of opioid dependence. In December 2012, Titan entered into a license agreement with Braeburn Pharmaceuticals Sprl (“Braeburn”) that grants Braeburn exclusive commercialization rights to Probuphine® in the United States and Canada. Titan received a non-refundable up-front license fee of $15.75 million and will receive a $50 million milestone payment upon the approval of the NDA by the FDA. Additionally, Titan will be eligible to receive up to $130 million upon achievement of specified sales milestones and up to $35 million in regulatory milestones in the event of future NDA submissions and approvals for additional indications, including chronic pain. Titan will receive tiered royalties on net sales of Probuphine ranging from the mid-teens to the low twenties. Probuphine is the first product to utilize ProNeura™, a novel, proprietary, long-term drug delivery technology. The ProNeura technology has the potential to be used in developing products for the treatment of other chronic conditions, such as Parkinson’s disease, where maintaining stable, round-the-clock blood levels of a drug can benefit the patient and improve medical outcomes. Finally, Titan is also entitled to royalty revenue of 8-10% of net sales of Fanapt® (iloperidone), an atypical antipsychotic compound being marketed in the U.S. for the treatment of schizophrenia by Novartis Pharma AG (“Novartis”) under a sub-license agreement based on a licensed U.S. patent that expires in October 2016 (does not include a possible six month pediatric extension). Substantially all of this future royalty revenue has been sold to Deerfield Management (“Deerfield”), a healthcare investment fund, in exchange for cash and debt considerations which have been used to advance the development of Probuphine and for general corporate purposes.
PebblePost is the leading digital-to-direct mail marketing platform. They capture online interest and intent data to send relevant direct mail that activates buying decisions at home and drives conversions everywhere. The company invented Programmatic Direct Mail to help brands convert more shoppers into buyers using advanced targeting, algorithmic optimization, attribution, and quantitative analysis. PebblePost is a venture-backed company based in New York.
IgnitionOne is a marketing technology and services that offers cloud-based customer intelligence solutions to enterprise marketers. It provides a customer intelligence platform that empowers marketers to find and engage their most valuable customers across channels to maximize overall results. Its solution also provides a single platform to leverage customer data from a range of systems to power effective omnichannel targeting and personalization. IgnitionOne was founded in 2004 and is based in New York, United States.
Strongbridge Biopharma’s primary focus has been to build its franchise around rare endocrine disorders, which includes product candidates for the treatment of endogenous Cushing’s syndrome and acromegaly, two rare diseases with a high unmet need for innovative treatment options. Given the well-identified and concentrated prescriber base addressing its target markets, the Company intends to use a small, focused sales force to market its products, if approved, in the United States, European Union and other key global markets. The Company intends to identify and in-license or acquire products or product candidates that would be complementary to its existing rare endocrine franchise or that would form the basis for new rare disease franchises.
Receptiv is the only in-app mobile video ad platform connecting brands to receptive users during meaningful moments to increase ad performance by 300 percent. Receptiv combines emotional targeting with precise audience intelligence via Motiv, its first-party data management platform built on insights from 150 million DeviceIDs. Founded as MediaBrix in 2011 and named an Adweek Top Mobile Innovator, Receptiv puts human experience at the center of digital advertising, available via both programmatic and managed service to create contextualized brand engagements during 500 million key moments every month, across more than 1,300 premium apps. Backed by investors including Edison Partners and Revel Partners, Receptiv delivers measurable value for the world’s leading brands, including Mars, Coca-Cola, Sprint, BMW, Microsoft, Wal-Mart, Merck, and 20th Century Fox.
ScoreBig.com is a leading destination for savings on Sports, Music and Theater tickets. At ScoreBig.com, consumers save up to 60% on tickets for Pro and College Sports, Music, Theater and Family events. ScoreBig.com has tickets to thousands of games and performances, from the rafters to the front row. ScoreBig.com is the first and only opaque sales channel available for the $20 billion live event industry. ScoreBig.com enables pro and college sports teams, and arts, music and theater organizations to move unsold tickets without the cannibalization risks inherent in traditional discounting. ScoreBig.com’s founders, investors and key executives have backgrounds in the NBA, NFL, Theater and Arts and leading ticketing, media and e-commerce companies. Founded in 2009, ScoreBig’s offices are located in Hollywood, California. ScoreBig.com was recently ranked No. 44 overall and No. 7 in Los Angeles on Deloitte’s Technology Fast 500.
Avalanche is a disruptive technology company developing innovative, ultra high performance enterprise solid-state storage arrays using tightly integrated hardware/software and leveraging its own non-volatile magnetic memory. Backed by top-tier investors and led by a veteran management team, we’ve amassed a distinctive portfolio of more than 200 cell, circuit, process and system patents.
Nomi is an omni-channel marketing platform that helps retailers better engage with their customers. It analyzes, measures, and optimizes the ROI of offline marketing and store operations initiatives. The channel quantifies the number of visitors each marketing campaign generates and calculate the lifetime value of customers acquired through each campaign; determines how effectively stores convert browsers into buyers thereby identifying underperforming staff and quantify how new training and management investments impact actual customer behavior; and offering a complete picture of the customer conversion funnel to allow retailers to predict the health of each store in order to diagnose operational bottlenecks before they impact the bottom line. Nomi was launched by Marc Ferrentino, Corey Capasso, Wesley Barrow, Peter Quintas, and Robert Balousek in September 2012 and is based in New York United States.
Digital Signal specializes in three-dimensional long-range facial recognition solutions for government and commercial clients. It offers enterprise biometric solutions and customized applications to suit customer needs. The company was founded in 2001 and is headquartered in Chantilly, Virginia.
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company's novel product pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.
Bridge2 Solutions is the leading innovator in the world of incentive, consumer and performance rewards. Bridging Performance Improvement agencies with best-in-class retail and service organizations to create a new business model for reward fulfillment that re-defines the industry.
Medsphere Systems Corporation provides open source software for the healthcare industry. It offers OpenVista, a portfolio of products and professional services for hospitals, clinics, and integrated delivery networks. The company's OpenVista includes OpenVista Enterprise, an electronic health record solution that offers patient and health information management system, clinical information system, laboratory, pharmacy, radiology, nutrition and food service, and interface suite modules. In addition, the company offers implementation, training, support, and development services. Medsphere Systems Corporation was founded in 2002 and is headquartered in Carlsbad, California.
SilkRoad Technology enables people to thrive in a changing workplace. Our software and services platform helps our clients attract, retain and align people to their business. Our solutions start with Global Client Services to provide strategic HR and business expertise. SilkRoad Technology then designs secure HR solutions tailored to business requirements at scale for global companies. We deliver personalized experiences for employees to drive engagement across the employment lifecycle and enable measurable and better business outcomes.
SavingStar is a paperless grocery rewards platform that enables shoppers to earn cash back. Shoppers earn cash on item-level grocery purchases with offers linked to their store loyalty cards and are validated when they submit a picture of their receipt at a number of retail locations nationwide. It automatically adds the value of each offer into members' SavingStar or partner accounts, enabling users to pick their payout from cash back or other currencies. The platform was launched in June 2010 and is based in Waltham, Massachusetts.
ScoreBig.com is a leading destination for savings on Sports, Music and Theater tickets. At ScoreBig.com, consumers save up to 60% on tickets for Pro and College Sports, Music, Theater and Family events. ScoreBig.com has tickets to thousands of games and performances, from the rafters to the front row. ScoreBig.com is the first and only opaque sales channel available for the $20 billion live event industry. ScoreBig.com enables pro and college sports teams, and arts, music and theater organizations to move unsold tickets without the cannibalization risks inherent in traditional discounting. ScoreBig.com’s founders, investors and key executives have backgrounds in the NBA, NFL, Theater and Arts and leading ticketing, media and e-commerce companies. Founded in 2009, ScoreBig’s offices are located in Hollywood, California. ScoreBig.com was recently ranked No. 44 overall and No. 7 in Los Angeles on Deloitte’s Technology Fast 500.
NinePoint Medical, Inc. is a transformational medical device company developing innovative, real-time, in vivo pathology devices. The company's first goal is to develop a device that enables remote pathology, or telepathology, which would facilitate immediate review of images during diagnostic procedures. This capability could potentially provide physicians with immediately actionable information and eventually allow them to pursue therapeutic remedies at the time of diagnosis. This convergence of access, diagnosis and treatment during one procedure is expected to improve patient experiences and outcomes, improve the efficiency of care and provide important savings to the healthcare system. Headquartered in Cambridge, Mass., NinePoint is backed by Third Rock Ventures and Prospect Venture Partners.
Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for treating diseases with significant unmet medical needs and commercial potential. Their programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Their primary product in clinical development is bremelanotide for treating female sexual dysfunction (FSD). In addition, they have drug candidates or development programs for obesity, erectile dysfunction, pulmonary diseases, cardiovascular diseases, and inflammatory diseases. Their current focus is on the design and development of receptor-selective melanocortin agonists for inflammation and autoimmune conditions, with a focus on ocular diseases. Their therapeutics work by activating endogenous melanocortin pathways to resolve damaging inflammation and allow affected tissues time to heal. Research has shown melanocortin agonists can prevent and reverse inflammation in disease models, including in the eyes and intestine—two of their targeted areas.
Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.
ZetrOZ is revolutionizing the ultrasound industry by introducing proprietary generator technology that is more efficient, more portable, and more economically viable than any ultrasound generator presently available.
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.
Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus. Its products include AGS-0031 for metastatic renal cell carcinoma; AGS-0041 for HIV; CD83 soluble protein for transplant rejection/autoimmune disorders; Anti IFN-alpha monoclonal antibody2 for lupus; and regulatory T cell therapy3 for autoimmune disorders. The company was formerly known as MERIX Bioscience, Inc. Argos Therapeutics was founded in 1997 and is based in Durham, North Carolina.
IntegenX, Inc. designs, manufactures, and markets automation systems that enable reliable microsample preparation and analysis for the life sciences. It offers Apollo 100, a platform that allows the processing of DNA sequencing reactions; Apollo 200, an integrated sample preparation system for human DNA identification; microfluidics for DNA sequencing, molecular diagnostics, and human identification applications; and Apollo 324 system, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing. The company was formerly known as Microchip Biotechnologies, Inc. and changed its name to IntegenX, Inc. in March 2010. The company was incorporated in 2003 and is based in Pleasanton, California.
SpringCM is a secure document and contract management platform used to solve critical business needs. SpringCM delivers affordable, easy-to-deploy document management and workflow solutions in a completely Web-based environment. SpringCM's award-winning ECM service eliminates software installations, hardware maintenance, and prolonged customization cycles associated with on-premises applications.
Founded in 1999, Mblox are the original SMS company. With over 100 direct carrier relationships and a global reputation for expertise in mobile messaging, they are trusted by more companies to carry their mission-critical traffic than any other service. Their cloud based mobile messaging platform processes 7 billion mobile messages a year on behalf of more than 4,000 customers. They provide services to fit any size business, from the small start-up to the largest multinational organisation. Every customer has access to 24/7 email support as standard, provided by an in-house team of experts. In addition they offer a variety of support packages to meet your business needs.
GenePeeks is a genetic information company with a mission to help families protect the health of future generations. Our patented technology previews a future child’s genetic profile, identifying disease risk impossible to observe with existing pre-conception screening tools. The company’s software digitally weaves together Next-Gen sequencing data from two prospective parents, simulating genetic recombination and reduction that occurs naturally in human reproduction. The process generates analytic targets that include tens of thousands of “virtual genomes.”
Social Intelligence Corp. provides social media data, analytics, tools, and reports to commercial and Government organizations. Headquartered in Santa Barbara, Calif., the company offers SaaS based search tools, predictive scoring algorithms, and proprietary data to deliver unparalleled solutions to reduce costs and keep companies and people safe. The company has developed a unique suite of products including employment background screenings, insurance claims investigations, corporate due diligence, and Government services. Social Intelligence adheres to the guidelines of the Fair Credit Reporting Act (FCRA) and is compliant with Federal and State law. Our team comes from the software, insurance, government services, and employment industries, and the Founders have worked with each other for more than 10 years. Social Intelligence was created to provide companies and governmental organizations publicly available online information, while ensuring this data is used appropriately and legally. With a dynamic group of more than 50 employees and quickly growing, our focus is on privacy, productivity, and community involvement above everything else. And not to be forgotten, the heart of our company, our mascot Browser Bulldog and his close friend Webster!
AccuVein specializes in vein visualization technology. Its flagship product, the AV400, is a hand-held, non-contact vein illumination solution. It allows healthcare professionals to see a map of peripheral veins on the skin’s surface with the goal of accessing or avoiding veins. It is built on proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies. The company was founded in 2006 and is headquartered in Medford, New York.
Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. All Mederi therapies are outpatient, minimally invasive, and promote rapid recovery. Mederi Therapeutics is located in Greenwich, Connecticut.
Inotek Pharmaceuticals is developing molecules with novel mechanisms of action to fulfill major unmet medical needs in significant diseases of the eye. Complete loss of vision or vision impairment currently affects 3.3 million people over the age of 40 in the United States, with the most common diseases including age-related macular degeneration (AMD), glaucoma, cataract and diabetic retinopathy. With the continued aging of the population, the National Eye Institute projects that this number will grow to 5.5 million people by the year 2020.
Overture Networks develops and manufactures high-speed carrier ethernet edge and aggregation solutions. Its products combine packet-switched and circuit-switched areas into a single architecture-at cost points to offer carrier Ethernet services to any size location over copper, fiber, or optical transport.
Valore operates an online marketplace designed for college students to buy, sell, and rent textbooks and other educational resources. Based in San Diego, ValoreBooks.com connects students with over 14,000 booksellers nationwide, offering textbooks at discounts of up to 90 percent off the list price, significantly lower than traditional campus bookstores. In addition to its extensive selection of affordable textbooks, Valore provides interactive tools and advice on college costs and student loans. The company is recognized for its commitment to customer service and for giving back to students, enhancing the overall educational experience.
Radisphere is the leading provider of standards-based radiology delivery solutions for health systems, with more than 100 clients in 28 states. We use cloud-based workflow management technology with advanced routing logic and 24/7 care management services to connect the hospitals and radiology groups across a system. By centralizing the management of radiology, Radisphere enables systems to leverage their own scale to deliver higher quality and lower cost care. Our clients can also standardize on our industry leading teleradiology services to enable final reads around-the-clock and scalable subspecialty coverage. Radisphere is transforming the practice of radiology at health systems by establishing measurable performance standards and accountability for diagnostic accuracy, appropriate utilization, service level excellence and patient care.
Enphase Energy brings a system-based, high-tech approach to solar energy, leveraging expertise in semiconductor integration, power electronics, and networking technologies to continually advance the performance, intelligence, and reliability of solar energy systems. Enphase's vision is to make solar simple and energy smart so everyone is empowered to create a zero-energy footprint for themselves, their home, and their business. Their mission is to build the world's finest networked energy system and revolutionize power generation on a global scale - one solar panel, a one-kilowatt hour at a time. Enphase Energy products make solar power systems productive, reliable, smart, and safe, increasing the energy harvest of solar panels by up to 25 percent.
Private Equity Round in 2009
Grab Media (formerly Grab Networks) is a leading premium video distribution company that connects premium video content from a wide collection of professional sources and brand-name advertisers to ideal viewers. Marketers rely on Grab Media to position their message in front of large-scale, engaged audiences, so they can focus on brand promotion.
Tagged.com was launched in 2004, and is an explosively growing social-networking portal developed specifically for teens aged 13 through 19. Emerging as the premier brand in the lucrative teen demographic, Tagged.com is rapidly becoming the number one teen site on the web.
Revance Therapeutics is a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems.
Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit's lead compound, AC220, is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML. Ambit is developing AC220 in collaboration with Astellas Pharma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. In addition to AC220, Ambit's clinical pipeline includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. Ambit also has a pipeline of preclinical candidates which includes CEP-32496, a BRAF inhibitor licensed to Cephalon.
COPAN Systems, Inc. provides massive array of idle disks storage solutions to unlock the value of long-term persistent data. The company offers virtual tape library products for backup/restore and disaster recovery applications; and archive products to retain digital assets with store and retrieve features at the file level. It offers data protection, archive, tiered storage, power and cooling, backup/restore, and disaster recovery solutions. The company’s customers include education, financial, government, healthcare, technology, media, and service provider industries. COPAN Systems, Inc. was founded in 2002 and is headquartered in Longmont, Colorado.
Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.